JNJ - Johnson & Johnson
Stock Analysis
Data: 2026-02-03us_universe.csv
- 2025IPOs.csv
- tb_sch.csv
- test_small.csv
- us_AI.csv
- us_cpu.csv
- us_Nuclear.csv
- us_penny_100.csv
- us_penny.csv
- us_Quantum.csv
- us_universe.csv
Last updated: Feb 03, 2026 at 7:07 PMFresh
show_chart Price & Trend 207.56 • 52W 141.50 - 215.19
Volume
Close
EMA9
MA50
MA150
MA200
Breakout
MA200 Reclaim
MA50 Touch
Pocket Pivot
PB Bounce
EMA9 Cross
auto_graph Pattern Recognition
info
info
Moderate pattern consistency: 54% win rate.
Signal Success Rate
54%
139 total signals
Avg Gain on Winners
+2.7%
75 wins
Avg Loss on Losers
-2.3%
64 losses
Recurring Behaviors
trending_up
Tendency to go on win streaks (longest: 17 signals in a row)
trending_down
Warning: Can experience losing streaks (longest: 11 signals)
Best Signal Type
Breakout
22 signals • 59% win rate
Avg gain: +0.3%
Worst Signal Type
PullbackBounce
31 signals • 45% win rate
Avg loss: -0.1%
All Signal Types (Best ? Worst)
Breakout
59%
22 signals
+0.3%
MA200Reclaim
57%
14 signals
+1.2%
PocketPivot
56%
70 signals
+0.5%
MA50Touch
50%
2 signals
-0.7%
PullbackBounce
45%
31 signals
-0.1%
Swing Cycle Analysis
Dominant pattern: ±3% every ~2.0 days (strength 0.49)
This stock shows a moderate ±3% swing pattern approximately every 2.0 days, though timing variability reduces reliability.
This stock exhibits a moderate ±3% swing about every ~2.0 days, suggesting upward bias with limited downside troughs and some repeatability but still variable timing.
| Swing | Avg Days | Strength | Pattern? |
|---|---|---|---|
| 3% | 2.0 | 0.49 Moderate | ? |
? Trough
? Peak(turning points)
This stock shows a moderate ±3% swing pattern approximately every 2.0 days, though timing variability reduces reliability.
assessment Key Metrics Universe Updated
Price
$207.56
Score
U
0.704
RS 6M
U
91
RS 3M
U
72
description Recommendation Summary
Buy
Confidence: 10/10
Performance: A Strong
R/C: 1.16:1
BUY (Confidence: 10/10) - Tight Base Breakout (VCP) | Strong Uptrend (Stage 2) | Strong Momentum (Sustained) | R/R 1.16:1 (Risk 3.2%) | High-Risk BUY
Trend
Strong Uptrend (Stage 2)
Momentum
Strong Momentum (Sustained)
Setup Type
Tight Base Breakout (VCP)
grade Absolute Rating
Hold
Standalone Technical Quality
check_circle
Trend Strength (Price > MA50, proper stack) (2 points)
cancel
13W Return ? +20% (0 points)
cancel
4W Return ? +8% (0 points)
check_circle
Up/Down Volume ? 1.10 (1 points)
check_circle
ATR(20) ? 3.5% (1 points)
cancel
Within 5%-25% of 52W High (0 points)
cancel
Risk/Reward ? 2:1 (R/R 1.16:1) (0 points)
Future Analytics
Coming soon...
security Risk Management
Suggested Stop Loss
$201.02
3.2% riskPotential Upside
+3.7%
R/R: 1.2:1Expected Move (20 d, ATR Proxy)
±$16.34 (7.9%)
Range: $191.22 - $223.90insights What It Means
The stock shows a mix of technical characteristics with strong relative strength and a solid composite score. Risk/Reward moderate (~1.2:1); catalysts or consolidation may improve it.
Positives
check_circle
Strong relative strength (RS6M 91, RS3M 72)
check_circle
High composite score 0.704
check_circle
Perfect moving average stack (healthy uptrend)
check_circle
Accumulation (Up/Down Vol 1.41)
Negatives / Risks
No major technical risksthumb_up Bullish Factors 8
check_circle
Elite 6m RS: 91th percentile (top 9%)
check_circle
Strong 3m RS: 72th percentile
check_circle
Perfect MA stack (MA50 > MA150 > MA200)
check_circle
Price above all major MAs (strong trend)
check_circle
Strong accumulation: 1.41x up/down volume
check_circle
Tight base: 27th percentile ATR (low volatility)
check_circle
Near 52-week high: -3.5% off peak
check_circle
Risk/Reward: 1.16:1 (Risk 3.2%, Reward 3.7% )
thumb_down Bearish Factors 2
cancel
Decelerating momentum (3m RS << 6m RS)
cancel
Mediocre R/R (<1.5:1)
analytics Technical Indicators
Current Price
$207.56
MA 50
$201.02
3.3%MA 150
$181.39
14.4%MA 200
$174.77
18.8%News & Sentiment
Last updated Feb 03 19:07
Sentiment line (?1..+1) with scaled article volume bars (height relative to sentiment range). Rolling 7d average smooths trend.
Positive day
Negative day
Neutral
Sentiment
7d Avg
Avg 7d: +0.10
Articles 7d: 55
Latest: 0.00 (2)Peak: +0.21 Feb 3
Johnson & Johnson stock price rises after RBC target hike as investors eye talc risk, new data - TechStock²
"JNJ stock" - Google News
Feb 03 6:00 PM
0.00
Johnson & Johnson stock price rises after RBC target hike as investors eye talc risk, new data TechStock²
BofA lifts PT on Johnson & Johnson (JNJ) to $227 from $221 – here’s why - MSN
"JNJ stock" - Google News
Feb 03 4:37 PM
0.00
BofA lifts PT on Johnson & Johnson (JNJ) to $227 from $221 – here’s why MSN
Johnson & Johnson (NYSE:JNJ) Trading 1% Higher After Analyst Upgrade - MarketBeat
"JNJ stock" - Google News
Feb 03 2:20 PM
+0.20
Johnson & Johnson (NYSE:JNJ) Trading 1% Higher After Analyst Upgrade MarketBeat
Why Johnson & Johnson stock is up today: new Varipulse Plus update puts AFib data back in play - TechStock²
"JNJ stock" - Google News
Feb 03 10:08 AM
0.00
Why Johnson & Johnson stock is up today: new Varipulse Plus update puts AFib data back in play TechStock²
Johnson & Johnson (NYSE:JNJ) Price Target Raised to $255.00 at Royal Bank Of Canada - MarketBeat
"JNJ stock" - Google News
Feb 03 7:22 AM
+0.10
Johnson & Johnson (NYSE:JNJ) Price Target Raised to $255.00 at Royal Bank Of Canada MarketBeat
What Does the Market Think About Johnson & Johnson? - Benzinga
"JNJ stock" - Google News
Feb 03 7:00 AM
0.00
What Does the Market Think About Johnson & Johnson? Benzinga
Bristol Myers Squibb launches campaign with Johnson & Johnson - marketscreener.com
"JNJ stock" - Google News
Feb 03 6:18 AM
0.00
Bristol Myers Squibb launches campaign with Johnson & Johnson marketscreener.com
What's Behind The 50% Surge In JNJ Stock? - Forbes
"JNJ stock" - Google News
Feb 03 5:32 AM
+0.10
What's Behind The 50% Surge In JNJ Stock? Forbes
Johnson & Johnson Stock Surges Nearly 50% - Eudaimonia and Co
"JNJ stock" - Google News
Feb 03 3:41 AM
+0.10
Johnson & Johnson Stock Surges Nearly 50% Eudaimonia and Co
Johnson & Johnson $JNJ Stake Decreased by Yacktman Asset Management LP - MarketBeat
"JNJ stock" - Google News
Feb 03 1:45 AM
+0.10
Johnson & Johnson $JNJ Stake Decreased by Yacktman Asset Management LP MarketBeat
Mawer Investment Management Ltd. Sells 8,150 Shares of Johnson & Johnson $JNJ - MarketBeat
"JNJ stock" - Google News
Feb 03 1:45 AM
+0.10
Mawer Investment Management Ltd. Sells 8,150 Shares of Johnson & Johnson $JNJ MarketBeat
Mediolanum International Funds Ltd Reduces Holdings in Johnson & Johnson $JNJ - MarketBeat
"JNJ stock" - Google News
Feb 03 12:19 AM
+0.10
Mediolanum International Funds Ltd Reduces Holdings in Johnson & Johnson $JNJ MarketBeat
Carrera Capital Advisors Invests $4.58 Million in Johnson & Johnson $JNJ - MarketBeat
"JNJ stock" - Google News
Feb 03 12:19 AM
+0.10
Carrera Capital Advisors Invests $4.58 Million in Johnson & Johnson $JNJ MarketBeat
Johnson & Johnson Stock Surged 50%, Here’s Why - Trefis
"JNJ stock" - Google News
Feb 02 11:06 PM
+0.10
Johnson & Johnson Stock Surged 50%, Here’s Why Trefis
What's Behind The 50% Surge In JNJ Stock?
JNJ stock - BingNews
Feb 02 8:32 PM
+0.10
In the nearly nine months spanning from May 2025 to February 2026, Johnson & Johnson (JNJ)’s stock experienced a remarkable 52% increase, driven ...
BofA lifts PT on Johnson & Johnson (JNJ) to $227 from $221 – here’s why
JNJ stock - BingNews
Feb 02 5:34 PM
0.00
Johnson & Johnson (NYSE:JNJ) is one of the best long term low volatility stocks to invest in. On January 30, BofA lifted the price target on Johnson & Johnson (NYSE:JNJ) to $227 from $221 while ...
Johnson & Johnson (NYSE:JNJ) Stock Price Up 1.6% Following Analyst Upgrade - MarketBeat
"JNJ stock" - Google News
Feb 02 2:25 PM
+0.20
Johnson & Johnson (NYSE:JNJ) Stock Price Up 1.6% Following Analyst Upgrade MarketBeat
ERLEADA And DARZALEX FASPRO Updates Shape Johnson And Johnson Oncology Story
JNJ stock - BingNews
Feb 02 10:55 AM
0.00
New clinical data supports ERLEADA for metastatic castration sensitive prostate cancer, reinforcing its role in current treatment practice. DARZALEX FASPRO received expanded FDA approval for newly ...
Johnson & Johnson stock rises as new Erleada survival data lands - TechStock²
"JNJ stock" - Google News
Feb 02 9:13 AM
0.00
Johnson & Johnson stock rises as new Erleada survival data lands TechStock²
Morgan Stanley Upgrades Johnson & Johnson to Overweight, Increases PT to $262 - Finviz
"JNJ stock" - Google News
Feb 02 7:21 AM
+0.10
Morgan Stanley Upgrades Johnson & Johnson to Overweight, Increases PT to $262 Finviz
National Pension Service Increases Stock Position in Johnson & Johnson $JNJ - MarketBeat
"JNJ stock" - Google News
Feb 02 3:01 AM
+0.10
National Pension Service Increases Stock Position in Johnson & Johnson $JNJ MarketBeat
Berman McAleer LLC Takes $6.20 Million Position in Johnson & Johnson $JNJ - MarketBeat
"JNJ stock" - Google News
Feb 02 2:55 AM
+0.10
Berman McAleer LLC Takes $6.20 Million Position in Johnson & Johnson $JNJ MarketBeat
Thrivent Financial for Lutherans Acquires 263,667 Shares of Johnson & Johnson $JNJ - MarketBeat
"JNJ stock" - Google News
Feb 02 12:40 AM
+0.10
Thrivent Financial for Lutherans Acquires 263,667 Shares of Johnson & Johnson $JNJ MarketBeat
Johnson & Johnson stock price: JNJ in focus after EU panel backs Akeega expansion - TechStock²
"JNJ stock" - Google News
Feb 01 7:36 AM
0.00
Johnson & Johnson stock price: JNJ in focus after EU panel backs Akeega expansion TechStock²
Tandem Investment Advisors Inc. Reduces Position in Johnson & Johnson $JNJ - MarketBeat
"JNJ stock" - Google News
Feb 01 1:17 AM
+0.10
Tandem Investment Advisors Inc. Reduces Position in Johnson & Johnson $JNJ MarketBeat
Summit Global Investments Decreases Stock Position in Johnson & Johnson $JNJ - MarketBeat
"JNJ stock" - Google News
Feb 01 1:05 AM
+0.10
Summit Global Investments Decreases Stock Position in Johnson & Johnson $JNJ MarketBeat
Looking for Passive Income in 2026? 3 Dividend Kings to Buy Hand Over Fist - The Motley Fool
"JNJ stock" - Google News
Jan 31 4:15 PM
0.00
Looking for Passive Income in 2026? 3 Dividend Kings to Buy Hand Over Fist The Motley Fool
Stock Scanner
- scienceTestingkeyboard_arrow_down
Stock Scanner v1.0.0
Copyright Ⓒ 2025